Dáil Éireann Debate, Wednesday - 15 September 2021
631. Deputy Bríd Smith asked the Minister for Health if he will take steps to ensure that all surplus Covid-19 vaccines, many of which are approaching their expiration date are immediately collected and dispatched to countries that need them; and if he will make a statement on the matter. [43466/21]
View answerIreland's COVID-19 vaccination programme strategy is to distribute all available vaccines as quickly as is operationally possible, prioritising those who are most vulnerable to COVID-19.
The programme is based on the principles of safety, effectiveness and fairness, with the objective of reducing severe illness, hospitalisations and deaths from COVID-19 infection. Ireland's COVID-19 vaccination programme will offer vaccination to all Irish residents for whom it is deemed safe, based on clinical expert guidance, and who wish to receive it.
Ireland is participating in a Procurement Exercise being operated by the European Commission on behalf of Member States to procure suitable, safe and effective vaccines, in sufficient quantities, to combat COVID-19. Four vaccines have been authorised by the EU, and a number of vaccine candidates are still to be fully assessed. Ireland fully supports efforts by the international community, including as an EU Member State, to ensure fair and equitable access to vaccines for all.
To contribute towards this objective, Ireland will utilise the sharing mechanisms available through the EU procurement structure. It is expected that COVAX will be central to this sharing mechanism. With the continuing progress of the domestic vaccination program, greater clarity on the available quantities of vaccines doses and the initial timing that these can be shared with COVAX, is becoming apparent. The Department is in current liaison with the Department of Foreign Affairs, the European Commission and COVAX to ensure that Ireland’s participation, in concert with other Member States, happens in a timely and proportionate manner.
